Investment
Features
FeesSafety
Academy
More
Pluang+

Northrop Grumman completes full inert Sentinel ICBM assembly, advancing toward 2027 test launch.

Market News
15 Sep 2026
Blockonomi
View Source
Bullish
Northrop Grumman completes full inert Sentinel ICBM assembly, advancing toward 2027 test launch.

Northrop Grumman and the U.S. Air Force successfully completed the vertical integration of a full-scale inert Sentinel intercontinental ballistic missile (ICBM) at Vandenberg Space Force Base, marking a key milestone in the missile's development. The four-month Pathfinder program tested transportation, assembly, and integration procedures, validating design and operational readiness ahead of the planned live test launch in 2027. This new missile system will replace the Minuteman III fleet and aims to be operational by the early 2030s, with service expected through 2075. The program involves over 500 suppliers and 10,000 personnel, highlighting its strategic importance for U.S. nuclear deterrence.

The Northrop Grumman Sentinel ICBM program reached a critical assembly milestone. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Sep 15, 2026 20:32 WIB: Of 50 major cryptocurrencies, 18 rose and 31 fell. Notable moves include UNI at Rp118.245 (+6.22%), BAT at Rp1.313 (-4.16%), and XLM at Rp3.487 (+3.53%).

More News

WasabiCard advances global payment partnerships and highlights APAC stablecoin payment needs at TOKEN2049.

WasabiCard advances global payment partnerships and highlights APAC stablecoin payment needs at TOKEN2049.

WasabiCard, a stablecoin-based global payment provider, engaged in key partnership discussions at TOKEN2049 Singapore 2026, focusing on white-label card issuing, global payouts, and embedded payments. The company highlighted growing demand in APAC fo...

Market News
Bullish
40 minutes ago
Next generation antibody therapeutics market to grow to $5.76B by 2035, driven by cancer and rare disease treatments

Next generation antibody therapeutics market to grow to $5.76B by 2035, driven by cancer and rare disease treatments

The global next generation antibody therapeutics market is projected to increase from $5.45 billion in 2026 to $5.76 billion by 2035, growing at a CAGR of 1%. Growth is fueled by advances in biotechnology, rising demand for targeted therapies, and in...

Market News
Bullish
1 hour ago
Global insurtech market to hit $638B by 2035, driven by AI, cloud, and automation with 41.45% CAGR

Global insurtech market to hit $638B by 2035, driven by AI, cloud, and automation with 41.45% CAGR

The global insurtech market is projected to grow from $14 billion today to $638 billion by 2035, at a compound annual growth rate of 41.45%. This rapid expansion is fueled by the adoption of AI, blockchain, cloud computing, machine learning, IoT, and...

Market News
Bullish
1 hour ago
EV wiring harnesses and connectors market to hit $29.43B by 2035, driven by high-voltage systems and EV growth

EV wiring harnesses and connectors market to hit $29.43B by 2035, driven by high-voltage systems and EV growth

The global market for wiring harnesses and connectors in electric vehicles is projected to grow from $8.53 billion in 2025 to $29.43 billion by 2035, at a CAGR of 12.83%. This growth is fueled by increasing EV production, adoption of battery electric...

Market News
Bullish
1 hour ago
Decentralized Clinical Trials market to reach $18.8B by 2030 with 13.7% CAGR driven by AI and digital tech.

Decentralized Clinical Trials market to reach $18.8B by 2030 with 13.7% CAGR driven by AI and digital tech.

The global Decentralized Clinical Trials (DCT) market, valued at $8.8 billion in 2025, is projected to grow to $18.8 billion by 2030, expanding at a CAGR of 13.7%. Growth is fueled by adoption of AI, wearables, cloud platforms, and flexible remote st...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App